SyndromeX is a pharmaceutical company that develops drugs for metabolic syndrome and related diseases such as dyslipidemia, type-2 diabetes, obesity, hypertension, and atherosclerotic cardiovascular disease.

In an effort to keep metabolic syndrome patients from having to take five to eight different drugs, SyndromeX aims to develop an all-in-one therapy for the disorder and its component diseases.